Rise In The Incidence Of Genetic Mutations Transpiring In The Global Population Is Driving The Growth Of The Transcriptomics Technologies Market

Transcriptomics Technologies Market: Market Overview

Transcriptomics is the study of transcriptomes and is a useful source for analyzing gene expressions and the functioning pattern of each gene in an organism.

According to the latest research by Fact.MR, the Transcriptomics Technologies market is set to witness a high growth rate during 2021-2031. The transcriptomics technologies market is set to achieve this steady growth during the forecast period due to factors such as the rise in applications of RNA sequencing applied in transcriptomic research. Growing funding by the government in genomic research also adds to the growth of the transcriptomics technologies market. Furthermore, the applications of transcriptomics in the discipline of toxicogenomics will fuel the future demand.

Request for Sample here –  https://www.factmr.com/connectus/sample?flag=S&rep_id=6115

Demand drivers for the Transcriptomics Technologies Market

A few driving factors for the demand of transcriptomics technologies market include the growth in the demand for personalized medicine and genetic testing for diseases and variation.

The global prevalence of diseases such as diabetes, hepatitis B and oncological disorders reinforces the importance of drug discovery and development and is a prime motivating factor for significant growth in the transcriptomics technologies market.

Apart from these factors, the rise in the incidence of genetic mutations transpiring in the global population due to the presence of carcinogens is considered as another major driving factor for the growth of the transcriptomics technologies market.

Technological advancements and their impact in the Transcriptomics Technologies market

Through technological advancements and upgradations, there is an increased rise in automation and these features are applicable in the transcriptome analysis methods like SAGE and amplification of nucleic acids. The use of these mentioned technologies in the analysis of gene expression will further augment the growth and uptake of RNA interference technologies and sequencing.

Request for Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6115

A key factor in the technology segment owing to the increase in demand for whole RNA sequencing and targeted resequencing is Next-generation sequencing.

U.S. and Canada Transcriptomics Technologies Market Outlook

The U.S. dominates the transcriptomics technologies market in the region of North America. The factors contributing to the significant market share of the country U.S. are associated with revenue through increasing R&D activities in the pharmaceutical and biotechnology industry.

Subsequently, North America is set to witness the fastest growth over the forecast period of 2021-2031 owing to the presence of previously overlooked market opportunities and growing acceptance of expenditure and conductive government initiatives.

The government of Canada has subjected significant funding in terms of transcriptomics technologies through several bodies which include not-for-profit organizations such as Genome Canada and has hence emerged as a subjective regional presence in the market for North America.

Europe Demand Outlook for Transcriptomics Technologies

The European transcriptomics technologies market is expected to grow at a profitable rate over the forecast period. This growth is owed to the presence of an increasing number of key players and the opportunistic approach to new investments in the field of transcriptomics technologies.

Furthermore, rising investments in the R&D sector in this region are set to generate momentum for new-age innovation in the transcriptomics technologies market and wound account for global growth in market size for the same.

Who are the Key Manufacturers and Suppliers of Transcriptomics Technologies?

Some of the key players in the Transcriptomics Technologies market include

• Danaher Corp
• Affymetrix Inc
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific
• LC Sciences
• Illumina, Inc.
• F-Hoffmann La Roche Ltd.
• Life Technologies Corporation
• GenXPro GmbH
• CD Genomics
• Merck KGaA
• Sequentia Biotech SL.

The major players in the transcriptomics technologies market are focusing on various organic strategies for growth such as new product launches and novel patented technologies. Apart from these, the strategy of acquisitions and collaborations within the key players in addition to technological advancements acting as a prime factor in maintaining their market presence.

 Pre-Purchase Enquiry – https://www.factmr.com/connectus/sample?flag=EB&rep_id=6115

Key Segments

By Product Type

• Analyzers
• Reagent Kits
• Software

By Technology

• Microarrays
• Gene Regulation Technologies
• Polymerase Chain Reaction
• Next-Generation Sequencing

By Application

• Clinical
• Diagnostics
• Toxicogenomics
• Comparative transcriptomics studies
• Drug discovery and research
• Bioinformatics

By End-use

• Academic Research and Government Institutes
• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology companies

By Region

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • BENELUX
  • Russia
• South Asia
  • India
  • ASEAN
  • Rest of Asia Pacific
• East Asia

• China
• Japan
• South Korea

• Middle East and Africa
  • GCC Countries
  • South Africa
  • Turkey

Read More Trending Reports of Fact.MR-

https://www.einpresswire.com/article/557298123/demand-for-independent-front-suspension-is-estimated-to-remain-high-owing-to-the-system-of-better-handling-stabilityWhy choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market

Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market

Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Japan Sales Office
Neha Bhosle, 4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
E: sales@factmr.com

The post Rise In The Incidence Of Genetic Mutations Transpiring In The Global Population Is Driving The Growth Of The Transcriptomics Technologies Market appeared first on Latest Market Reports.